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Genetic risk is a flashpoint for many scholars of the rhetoric of health and medicine, as it
involves a complicated calculus for the patient and for the rhetorical scholar. Kelly Pender’s
book, Being at Genetic Risk: Toward a Rhetoric of Care, takes up the question of genetic risk
through her analysis of patients who test positive for the BRCA gene and then must decide if
they will choose surgery or surveillance.
Her work questions the current conceptions of genetic risk. Pender cites the work of Annemarie
Mol (2008), which questions the concept of a rational decision- maker patient role, “who, by
weighing various options and exercising their purchasing power, can take control of their health”
(p. 1). Pender’s reading of Mol points out that a logic of choice is “shaped by a false binary
between a paternalistic paradigm in which doctors make all the decisions and a civic/consumerist
one in which patients can have what they want, this logic values and, indeed, valorizes a type of
freedom that is beyond the reach of most patients” (p. 1). Pender cites a long rhetorical history of
genetic risk and calls into question the current understandings of critique and constructivism as
productive for those at risk by noting that her rhetoric of choice model provides, “a set of
predictable but also well-meaning and perhaps even noble gestures that are important in form but
almost entirely meaningless in substance” (p. 42). Instead, Being at Genetic Risk asks us to
consider differently the problem of choice in genetic risk by demonstrating that patients at
genetic risk do not need further critiques of the logic of choice, but rather an alternative that
embodies the way those at risk think and talk about their experiences.
Pender asks us to consider an alternative way to consider genetic risk. Pender advocates for a
rhetoric of care that provides, “a set of conceptual starting places, or topoi, that can be used to
foster a rhetoric of care by highlighting those elements of being at risk that choice … obstructs
from view.” (p. 2). In order to do so, Pender invokes techne as a way to rethink invention to,
“provide inventive responses to the kinds of wicked problems that more traditional forms of
critique have been unable to solve” (p. 3). Pender’s work situates itself within what she cites as a
move within the discipline toward invention as rhetorical practice to “provide inventive
responses to the kinds of wicked problems that more traditional forms of critique has been
unable to solve.” (p. 3). To accomplish this goal, Being at Genetic Risk provides a thorough
rhetorical analysis of guidebooks, interviews with BRCA patients, and discussion forum
postings, as well as a praxiographic approach to MRI breast scans. Pender argues for a shift in
the way that genetic risk is approached and conceptualized for scholars and patients. Her analysis
pushes the reader to move beyond the binary of constructivism to consider that the language of
rhetoric of choice for those who must make sense of genetic risk is, “as poor an ideal for those
whose genes predispose them to a disease as it is for those who have a disease” (p. 1).
Students and scholars of rhetoric are encouraged by Being at Genetic Risk to rethink invention in
ways that move away from a “hermeneutics of suspicion,” (p. 3) to instead focus on how rhetoric
can be made to perform in relation to genetic risk. To this end, Being at Genetic Risk is broken
into four chapters which address both rhetorical and genetic risk concepts. In chapter 1, Pender
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addresses the work of Mol (2008) as an entry point for rhetorical scholars to shift toward a
rhetoric of care. Citing Mol’s Logic of Care, Pender argues that genetic risk, such as BRCA
testing and the resultant choices, are similar to and as worthy of attention as chronic diseases,
such as diabetes in the case of Mol’s work (2008). Pender provides a basic explanation of BRCA
mutations in carcinogenesis. Pender notes that her explanation is basic, “owing to the fact that I
am not a molecular biologist” (p. 12). However, a basic explanation is all that is needed as the
goal of the chapter is not provide in-depth molecular biology, but to address how a rhetoric of
care would function rhetorically. Pender demonstrates that the language of choice is misleading
in the case of BCRA, even as the medicine and those diagnosed are faithful to rhetorics of
autonomous decision making, nondirectiveness, and empowerment through knowledge, even
when it is clear that choices are not freely made. Pender cites recommendations from the
National Comprehensive Care Network as reinforcing the language of choice, even while Pender
demonstrates that the “previvor” status of BRCA testing means that women do not have as much
choice as the language would lead one to believe.
In chapter 2, Pender moves from a description of the rhetoric of care and the rhetoric of choice to
addressing constructivist critiques of genetic medicine and risk. Being at Genetic Risk argues for
scholars to move away from critiques centered in ideology, which argue for hidden ideological
forces which scholars must expose. Pender cites a body of literature that focuses on eugenic
intent as a predominate force in ideologic critiques as coming to similar conclusions, including
the work of Abby Lippman (1991), Troy Duster (1990), Ivan Illich (1976), and Henk Ten Have
(2001). While Pender notes that issues of race, gender, class, and sexuality are important and that
“the destructive potential of genetic risk is so great” (p. 59), she urges movement beyond
unmasking to a perspective of governmentality. Drawing from the work of noted sociologist
Deborah Lupton (2000) and the work of Francois Ewald and Robert Castel (1991), Pender
examines how governmentality points critics to different channels of power which encourage
self-policing of patients and “to pursue risk-free lives” (p. 63). This shift from unmasking forces
that constrain to acknowledging how subjects self-constrain then allows Pender to argue that the
question scholars should attend to, “isn’t just how … fear of breast cancer persuade[s] women to
remove healthy breasts but also what is happening to make risk appear real” (p. 66). Pender notes
the “construction of at-risk women as patients without symptoms” (p. 67) obscures the difference
between having cancer risk and having cancer. This empowers a hegemonic prophylactic
mastectomy narrative which encourages patients to treat their risk as always already developing
cancer.
In chapter 3, Pender introduces praxiographic inquiry as an alternative way to understand the
risks of BRCA, noting that discourses of ideological critique require the critic to play the role of
debunker in rhetoric of choice, which end up reinscribing those norms. Pender asks us instead to
turn to LaTour’s praxiographic inquiry as a way to get close to objects of medicine or science,
without critiquing or debunking them (2007). Instead, Pender addresses how women enact
BRCA risk every day, “through practices that compress, palpate, and image their bodies” (p. 73),
which she investigates through analysis of mammography and breast MRI cancer screening
processes through focus on “practicalities, material objects, technologies, and techniques” (p.
82). Through her careful attention to the “logistical messiness” of BRCA risk, Pender
demonstrates that risk is not just something patients know, but something patients do that has
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reality and material consequence in their lives. The trade offs that cancer patients, and supposed
cancer patients (those yet without symptoms), make is logistically and emotionally taxing.
Finally, in chapter 4, Pender returns the concept of rhetoric of care, this time through the lens of
architectonical rhetoric. She notes that her goal is not to single-handedly create a rhetoric of care,
but to “offer ‘discoveries’ that [she has] made through [her] engagements with BRCA-related
discourses” (p. 103). To this end, Pender notes she diverges from much of the rhetoric of science,
technology, and medicine (RSTM) work in that she doesn’t, “aim to explain what is happening
in the ‘substantive field’ as much as [she] aims to change it” (p. 103) by focusing on invention as
opposed to interpretation. Consequently, Pender turns her attention then not to interpretation of
risk, but to how patients make sense of BRCA testing through ongoing clinical risk assessments,
concern for quality of life to both those who choose prophylactic surgery and those who eschew
it, and the recognition that often choice for BRCA patients is “between the devil and deep” (p.
130), meaning that having choices does not mean having good choices, but rather working to
choice the least terrible option. Pender’s shift away from interpretation then allows her
interviewees to speak for themselves as they participate in the invention of choice, and the
sensemaking of choice, in on-going, perilous, and messy logistical situations.
Being at Genetic Risk is an ambitious work that aims to provide alternative methodology from
critique and ideology in rhetorical studies of genetic risk, even as the author admits that no one
work could entirely create a rhetoric of care for the at-risk. In the case of BRCA testing, and
subsequent risk management, the author shares her personal story as an opening, elucidating how
those who manage risk are positioned and prodded by “previvorship,” cultural expectations, and
the field of medicine, which Pender supports with careful analysis of interviews, discussion
posts, and guidebooks throughout her work. Pender’s call for a move from reductive critiques to
a realization of the material risks and messy logistics of being BRCA positive are insightful and
compelling for future studies of genetic risk. While this work may suffer a bit for the RHM
reader from the effort to exhaustively explain theoretical choices, in doing so it is clear that
Pender adds substantially to the work of rhetorical theory by drawing on multi-disciplinary fields
to support future directions for rhetorical studies of risk through examining compulsory rhetorics
of choice, exploring governmentality as alternative to ideology, and making space for rhetorical
invention in risk.
Pender’s Being at Genetic Risk is a contribution to RHM as it adds to the body of knowledge
about the rhetoric of breast and ovarian cancers, as well as adding substantially to rhetorical
theory. Pender’s focus on what the rhetoric of choice obscures for those at genetic risk of BRCA
provides many in-roads for rhetorical scholars of all stripes, including those studying breast and
ovarian cancer in many contexts.
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